NOVELTY – Polymeric nanofibers comprise polymeric structure that is incorporated with essential oil of Copaifera langsdorffii and Cymbopogon nardus. USE – Polymeric nanofibers for use in field of textile industry, packaging industry and regenerative medicine for wound healing, and for production of ultra-filtration membranes (claimed). ADVANTAGE – The polymeric nanofibers ensure good biocompatibility.
A96 (Medical, dental, veterinary, cosmetic.); F01 (Threads and fibres – natural or artificial; spinning – including the production of mineral and carbon fibres (D01).); D22 (Sterilising, bandages, dressing and skin protection agents – including sterilising agents (other than for food), sutures, plaster casts, bioactive prostheses, contact lenses, diapers, animal litter, timber, preservatives, disinfectants, bactericidal detergents, deodorants, insect repellent compounds, moth proofers, sheep dip (A61L).); B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.); A85 (Electrical applications.); B05 (Other organics – aromatics, aliphatic, organo-metallics, compounds whose substituents vary such that they would be classified in several of B01 – B05.); P34 (Sterilising, syringes, electrotherapy (A61L, M, N).)